Bleakley Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Buy
38,445
+5,515
+17% +$1.89M 0.18% 97
2026
Q1
$11.6M Buy
32,930
+3,526
+12% +$1.26M 0.18% 100
2025
Q4
$9.62M Buy
29,404
+1,965
+7% +$623K 0.17% 101
2025
Q3
$7.74M Buy
27,439
+126
+0.5% +$36.5K 0.18% 102
2025
Q2
$7.63M Buy
27,313
+4,588
+20% +$1.3M 0.19% 97
2025
Q1
$7.08M Buy
22,725
+1,570
+7% +$464K 0.23% 85
2024
Q4
$5.51M Sell
21,155
-1,085
-5% -$322K 0.17% 104
2024
Q3
$7.17M Buy
22,240
+507
+2% +$166K 0.22% 75
2024
Q2
$6.79M Buy
21,733
+732
+3% +$215K 0.2% 98
2024
Q1
$5.97M Buy
21,001
+425
+2% +$124K 0.17% 117
2023
Q4
$5.93M Sell
20,576
-377
-2% -$103K 0.19% 103
2023
Q3
$5.63M Sell
20,953
-1,278
-6% -$319K 0.2% 99
2023
Q2
$4.94M Buy
22,231
+1,224
+6% +$284K 0.15% 122
2023
Q1
$5.08M Buy
21,007
+306
+1% +$75.1K 0.17% 108
2022
Q4
$5.44M Buy
+20,701
New +$5.55M 0.19% 104

Other funds holding AMGN

Bleakley Financial Group's AMGN Position: Q2 2026 in Review

Bleakley Financial Group increased its Amgen (AMGN) stake by 17% in Q2 2026, buying an estimated $1.89M and bringing the position to 38,445 shares worth $13.9M. The position accounts for 0.18% of the portfolio, ranked #97.

Bleakley Financial Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bleakley Financial Group held 38,445 shares of Amgen worth $13.9M as of Q2 2026.
  • Bleakley Financial Group bought 5,515 Amgen shares in Q2 2026, an estimated $1.89M.
  • Amgen made up 0.18% of Bleakley Financial Group's portfolio in Q2 2026, its #97 holding.
  • Bleakley Financial Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.